Strategie zur Herstellung rekombinanter Antikörper. Die Antigen Bindungstasche des DEC Ab (a) wird kloniert und über einen Linker zu sog. Single-Chain Antibodies (ScFv) verknüpft (b). An diese ScFv können nun Tumorantigene (TA) mittels Klonierung angehängt und zur Zielsteuerung verwendet werden. Desweiteren ist es möglich die alphaDEC-ScFv mit einem anti-Adenovirus ScFv zu fusionieren (c). Man erhält so einen "Linker-Antikörper", der die Bindung von Adenoviren an DEC+DCs vermittelt.
Quelle: Arbeitsgruppe Prof. Enk
(12 KB, 381 x 216 pixels)
In regard to the use of pictorial material: use of such material in this press release is remuneration-free, provided the source is named. The material may be used only in connection with the contents of this press release. For pictures of higher resolution or inquiries for any further use, please contact the Press office publishing this directly.
Wir are looking for a
science communicator for the idw e.V.
You find all relevant [...]
We are now also publishing our members' press releases from the categories research results, [...]
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).